Evaluation of the safety of ivermectin-praziquantel administered orally to pregnant mares

American Journal of Veterinary Research

Volumn 64, Issue 10, 2003, Pages 1221-1224

  Mercier, Patrick ^a,d   Alves Branco, Francisco ^a,b   Sapper, Maria de Fatima ^a,b   White, Christopher Roger ^c  

^a Virbac SA   (France)

^b Consultorio Medico Veterinario ^*  (Brazil)

^c Virbac do Brasil Laboratories ^*  (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; PLACEBO; PRAZIQUANTEL;

ABORTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL HEALTH; ARTICLE; BLOOD CHEMISTRY; BLOOD COMPONENT; BREEDING; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; EMBRYO DEVELOPMENT; FEMALE; FETUS DEVELOPMENT; FETUS DISEASE; FOLLOW UP; GESTATION PERIOD; HEMATOLOGICAL PARAMETERS; HORSE; LACTATION; NONHUMAN; PHYSICAL EXAMINATION; PREGNANCY; PUERPERIUM; RANDOMIZATION;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; DRUG COMBINATIONS; FEMALE; HORSES; IVERMECTIN; PRAZIQUANTEL; PREGNANCY; PREGNANCY, ANIMAL; SAFETY;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0141921446     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.1221     Document Type: Article

References (19)

1. Chabala JC, Mrozik H, Tolman RL, et al. Ivermectin, a new broad-spectrum antiparasitic agent. J Med Chem 1980;23:1134-1136.
2. Egerton JR, Birnbaum J, Blair LS, et al. 22-23 Dihydroavermectin B1, a new broad-spectrum antiparasitic agent. Br Vet J 1980;136:88-97.
3. Campbell WC, Fisher MH, Stapley EO, et al. Ivermectin: a potent new antiparasitic agent. Science 1983;221:823-828.
4. Andrews P, Thomas H, Pohlke R, et al. Praziquantel. Med Res Rev 1983;3:147-200.
5. Gönnert R, Andrews P. Praziquantel, a new broad-spectrum anti-schistosomal agent. Z Parasitenkd 1977;52:129-150.
6. Martindale W. Ivermectin. In: Reynolds JEF, ed. The extra pharmacopoeia. 30th ed. London: The Pharmaceutical Press, 1993;43-44.
7. Martindale W. Praziquantel. In: Reynolds JEF, ed. The extra pharmacopoeia. 30th ed. London: The Pharmaceutical Press, 1993;52-53.
8. Campbell WC, Benz GW. Ivermectin: a review of efficacy and safety. J Vet Pharmacol Ther 1984;7:1-16.
9. Egerton JR, Seward RL, Robin B. Ivermectin as an antiparasitic agent for horses, in Proceedings. 22nd World Vet Cong, MSD AGVET Symp Recent Dev Control Anim Parasites 1983;49-55.
10. Ooms L, Oyaert W, Muylle E, et al. Electrophoresis as an aid to the diagnosis of helminthiasis and especially of verminous aneurysms in horses. Vlaams Diergeneeskundig Tijdschrift 1976;45:290-299.
11. Velichkin PA. Nodular trichonematosis of the large intestine in stud horses. Izv Moskov Zootekhnich Instit Konevod 1952;7:18-25.
12. Smith HJ. Strongyle infections in ponies II. Re-infection of treated animals. Can J Comp Med 1976;40:335-340.
13. Asquith RL, Kulwich R. Safety and therapeutic activity of ivermectin as an equine anthelmintic. Equine Vet Sci 1981;1:18-20.
14. Leaning WHD. The efficacy and safety evaluation of ivermectin as a parenteral and oral antiparasitic agent in horses, in Proceedings. Am Assoc Equine Pract Annu Meet 1983;29:319-328.
15. Lee Chin SH, Lu AH. Metabolism and tissue residues. In: Campbell WC, ed. Ivermectin and abamectin. New York: Springer-Verlag Inc, 1989;131-143.
16. Masimirembwa CM, Hasler JA. Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. Biochem Pharmacol 1994;48:1779-1783.
17. Jones WE. Genetics and horse breeding. Philadelphia: Lea & Febiger, 1982;460-490.
18. Bergin WC, Gier HT, Frey RA, et al. Developmental horizons and measurements useful for age determination of equine embryos and fetuses, in Proceedings. 13th Annu Conv Am Assoc Equine Pract 1967;179-196.
19. McKissick GE, Sutherland IH, Foix J, et al. The safety of ivermectin administered orally to pregnant mares. Equine Vet Sci 1987;7:357-367.